Improving Access to Critical HIV Treatments

ViiV Healthcare Patient Assistance Program (PAP) offers important HIV medicines—at little or no cost—to qualified patients

The fight against HIV has become a global effort, which is why in 2009, GlaxoSmithKline and Pfizer joined forces to form the global specialist HIV company, ViiV Healthcare. ViiV Healthcare is committed to advancing the treatment and care of people living with HIV and to broadening access to medicines for people who require life-saving treatment.

ViiV Healthcare Patient Assistance Program makes necessary HIV treatments available to more patients. If you or someone you know needs help paying for HIV treatment, find out whether you may be eligible for ViiV Healthcare Patient Assistance Program.

Two Ways to Enroll

By Mail or Fax—For Patients Who Want to Self-Enroll

Patients may enroll in ViiV Healthcare Patient Assistance Program on their own by completing an application and submitting it by mail or fax.

By an Advocate—When Medicine Is Needed Right Away for Patients Who Are Not Enrolled in a Medicare Part D Prescription Drug Plan.

Non Medicare Part D patients who need medicine that same day should ask their Advocate (ie, anyone involved in the delivery of the patient's healthcare who is not a family member or friend) to enroll them in ViiV Healthcare Patient Assistance Program
by phone.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.